Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Apremilast did not work for treating severe alopecia areata.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Dupilumab can cause lupus-like symptoms, so patients need careful monitoring.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

IVIg treatment improved symptoms but caused permanent dark hair loss.

More research is needed to understand and manage angioedema in pregnant women with lupus.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Inflammation, possibly triggered by a specific bacteria and activated by UV radiation, may contribute to male pattern baldness.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Prolonged UVB exposure causes significant skin changes and damage in rats.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

A rare skin condition called linear lichen planopilaris caused itchy red bumps and hair loss on a man's face.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

SCAD can indicate ANA-negative lupus, especially in women with unusual symptoms.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.